DarioHealth EPS DRIO
Diluted earnings per share by quarter and over the last twelve months, from 2012.
- Last 12 months, to Jun 30, 2026
- $3.91
- Latest quarter, Q2 FY26
- $0.85
- −76% on a year earlier
- Fiscal year 2025
- $8.22
- +2% on the year before
DarioHealth's earnings per share was $3.91 over the twelve months to Jun 30, 2026, down 56% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.85, down 76% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $8.22 | +2% |
| FY2024 | $8.06 | −61% |
| FY2023 | $20.60 | −35% |
| FY2022 | $31.80 | −14% |
| FY2021 | $37.00 | n/a |
| FY2020 | −$80.00 | n/a |
| FY2019 | −$216.60 | n/a |
| FY2018 | −$336.00 | n/a |
| FY2017 | −$712.00 | n/a |
| FY2016 | −$928.00 | n/a |
| FY2015 | −$1676.00 | n/a |
| FY2014 | −$35.78 | n/a |
| FY2013 | −$21.51 | n/a |
| FY2012 | −$2.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.85 | −76% | $3.91 | |
| Q1 FY26 | $1.25 | −56% | $6.60 | |
| Q4 FY25 | −$1.15 | n/a | $8.22 | |
| Q3 FY25 | $2.96 | −40% | $6.92 | |
| Q2 FY25 | $3.54 | +121% | $8.87 | |
| Q1 FY25 | $2.87 | −28% | $6.93 | |
| Q4 FY24 | −$2.45 | n/a | $8.06 | |
| Q3 FY24 | $4.91 | −50% | $0.71 | |
| Q2 FY24 | $1.60 | −86% | $5.60 | |
| Q1 FY24 | $4.00 | −56% | $15.60 | |
| Q4 FY23 | −$9.80 | n/a | $20.60 | |
| Q3 FY23 | $9.80 | −23% | $19.80 |
Against its peers
Companies in Medical - Instruments & Supplies nearest DarioHealth's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DRIODarioHealth | $3.91 | −56% a year |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| Peer median | $1.58 |
Where DarioHealth ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on DarioHealth
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.